Charles Fuchs, MD: Strategies to Increase RAS Testing

What strategies can be used to increase the percentage of patients who receive recommended RAS testing?

It's really important and incumbent upon us to make sure that these data are available to all practicing oncologists. ASCO, OncLive, and other organizations are doing a good job proliferating that information, making sure that busy practitioners are aware of the data that RAS and KRAS and NRAS specifically decide for us whether a patient should get an EGFR receptor inhibitor, and that you should not be making these treatment decisions without obtaining that testing.

Unresectable Colon Cancer: Case 2

52-year-old woman newly diagnosed with metastatic CRC and is genotyped as part of her initial work up.